Media Database
>
Bruce Japsen

Bruce Japsen

Senior Contributor at Forbes

Contact this person
Email address
b*****@*******.comGet email address
Influence score
64
Location
United States
Languages
  • English
Covering topics
  • Business
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

forbes.com

U.S. Awards 400 New Residencies As Down Payment On Doctor Shortage

The Centers for Medicare & Medicaid Services is distributing a much-needed batch of 400 new Medicare-supported physician residencies to hospitals across the U.S.
forbes.com

Obamacare New Sign-Ups Lag Last Year’s Pace With Subsidies In Limbo

New sign-ups for in individual coverage under the Affordable Care Act, also known as Obamacare, lags last year’s pace.
forbes.com

Humana And Mark Cuban’s Cost Plus Drugs Working On Partnership To L...

The health insurance giant Humana and Mark Cuban’s Cost Plus Drugs are discussing ways to partner to lower the cost of prescription drugs for U.S. employers.
forbes.com

1 In 4 Obamacare Enrollees May Drop Coverage If Tax Credits Go Away...

One in four Obamacare enrollees will “very likely go without” coverage if premiums doubled thanks to the loss of tax credits, a new KFF poll shows.
forbes.com

GOP Support Slowly Grows For Obamacare Subsidy Extension

More Republicans are voicing support for an extension of tax credits for those who buy individual coverage under the Affordable Care Act, also known as Obamacare.
forbes.com

Health Insurer Stocks Reflect Obamacare Subsidy Deal Can Be Reached

Health insurance company stocks rose again Wednesday amid hope the Trump administration and Congress can agree on an extension of tax credits for those who buy Obamacare.
forbes.com

Health Insurer Stocks Jump On News Obamacare Subsidies To Be Extended

Health insurer stocks rose on news the Trump administration will float an extension of tax credits for those who buy individual coverage under the Affordable Care Act.
forbes.com

Abbott’s $21 Billion Exact Sciences Deal Fills Void Of Lost Covid T...

Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic division that has lost sales from COVID tests.
forbes.com

UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board

UnitedHealth Group named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
forbes.com

Staffing Worsens At Doctor Practices As Worker Shortage Drags On

Staffing of physician practices and medical groups continues to stagnate or worsen by some measures with doctors busier than ever, an AMGA Consulting analysis shows.
forbes.com

Obamacare Insurer Oscar Health Sees 2026 ‘Return To Profitability’

Oscar Health reported a $137 million loss but predicts a 2026 return to profitability as health insurers work through a period of rising costs and Washington gridlock.